Mark E. McGovern
Corporate Officer/Principal presso American College of Physicians
Profilo
Mark E.
McGovern is a professional with current positions as a Member at the American College of Cardiology Foundation and a Member at the American College of Physicians.
He previously worked as an Executive Director-Heart Failure at Bristol Myers Squibb Co. from 1986 to 1997 and as the Chief Medical Officer & Executive Vice President at KOS Pharmaceuticals, Inc. from 1997 to 2007.
He also served as an Independent Director at Esperion Therapeutics, Inc. from 2014 to 2022.
McGovern received his undergraduate degree from Princeton University and his doctorate from the University of Vermont.
Posizioni attive di Mark E. McGovern
| Società | Posizione | Inizio |
|---|---|---|
American College of Physicians
 American College of Physicians Miscellaneous Commercial ServicesCommercial Services The American College of Physicians operates as a medical-specialty organization. The non-profit company is based in Philadelphia, PA. Darilyn V. Moyer has been the CEO of the company since 2016. | Corporate Officer/Principal | - |
American College of Cardiology Foundation
 American College of Cardiology Foundation Medical/Nursing ServicesHealth Services American College of Cardiology Foundation provides cardiovascular education services. Its services include cardiac surgery, chronic angine, diabetes, geriatric cardiology and heart failure and cardiomyopathies. The company was founded by Franz Groedel, Robert P. Glover and Bruno Kisc in 1949 and is headquartered in Washington, DC. | Corporate Officer/Principal | - |
Precedenti posizioni note di Mark E. McGovern
| Società | Posizione | Fine |
|---|---|---|
| ESPERION THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 28/04/2022 |
KOS Pharmaceuticals, Inc.
 KOS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology KOS Pharmaceuticals, Inc. operates as pharmaceutical company that developed and commercialized proprietary prescription products for the treatment of chronic cardiovascular, metabolic and respiratory diseases. The company is founded by Daniel M. Bell and Michael Jaharis in 1988 and is headquartered in Cranbury, NJ. | Direttore Tecnico/Scientifico/R&S | 01/01/2007 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/01/1997 |
Formazione di Mark E. McGovern
| Princeton University | Undergraduate Degree |
| University of Vermont | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| ESPERION THERAPEUTICS, INC. | Health Technology |
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| Aziende private | 3 |
|---|---|
KOS Pharmaceuticals, Inc.
KOS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology KOS Pharmaceuticals, Inc. operates as pharmaceutical company that developed and commercialized proprietary prescription products for the treatment of chronic cardiovascular, metabolic and respiratory diseases. The company is founded by Daniel M. Bell and Michael Jaharis in 1988 and is headquartered in Cranbury, NJ. | Health Technology |
American College of Physicians
American College of Physicians Miscellaneous Commercial ServicesCommercial Services The American College of Physicians operates as a medical-specialty organization. The non-profit company is based in Philadelphia, PA. Darilyn V. Moyer has been the CEO of the company since 2016. | Commercial Services |
American College of Cardiology Foundation
American College of Cardiology Foundation Medical/Nursing ServicesHealth Services American College of Cardiology Foundation provides cardiovascular education services. Its services include cardiac surgery, chronic angine, diabetes, geriatric cardiology and heart failure and cardiomyopathies. The company was founded by Franz Groedel, Robert P. Glover and Bruno Kisc in 1949 and is headquartered in Washington, DC. | Health Services |
- Borsa valori
- Insiders
- Mark E. McGovern
